CTOs on the Move

VistaGen

www.vistagen.com

 
VistaGen (Nasdaq: VTGN) is a late clinical-stage, CNS-focused biopharmaceutical company striving to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The Company is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those that are currently available. VistaGen`s clinical-stage candidates are targeting multiple forms of anxiety and depression. They belong to a new class of drugs known as pherines, which are odorless, tasteless, neuroactive steroids that bind to distinct receptors on chemosensory neurons in the nasal passages and can impact the limbic amygdala without systemic uptake ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.vistagen.com
  • 343 Allerton Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.577.3600

Executives

Name Title Contact Details

Similar Companies

RESTAT

RESTAT is a West Bend, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanōmix

Nanōmix is the leader in mobile point-of-care diagnostics for use where time and accuracy is critical.

Quark Pharmaceuticals

Quark Pharmaceuticals is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Teva Canada

Teva Canada is a Scarborough, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.